Default Category
-
Canon Inc.: Ambitious Acquisitions in the Video Surveillance Market
Wiboon Kittilaksanawong; Andrew Jiro PoplawskiCase IVEY-9B16M101-EEntrepreneurship, StrategyFacing a decline in the company’s core camera business as a result of the aggressive entry of smartphones, Canon identified the network security industry as a potential growth market, with expected revenues of US$23 billion by 2020. Canon opted to pursue this kind of growth potential outside its core competency by acquiring Milestone Systems in 2014 and Axis Communications in 2015. Canon paid a 50-per-cent premium to acquire Axis in a cash-only o...Starting at €8.20
-
Brooks Sports: Competing against the Giants
Wiboon Kittilaksanawong; Andrew Jiro PoplawskiCase IVEY-9B16M150-EEntrepreneurship, StrategyBrooks Sports, Inc. (Brooks) strove to inspire and promote an active lifestyle through its innovative gear, enabling its customers to run longer, farther, and faster. The shoe company had endured a number of growths and declines in its 100 years of operations. Nearly bankrupt by 2000 because of its attempt to compete with diversified athletic brands, Brooks had finally found a strategy to compete in the sports market. Operating as an independent ...Starting at €8.20
-
Mazda Motor Corporation: Surviving by Partnering with the Giants
Wiboon Kittilaksanawong; Tae Kyung Lee; Andrew Jiro PoplawskiCase IVEY-9B17M117-EEntrepreneurship, StrategyFor 30 years, Mazda Motor Corporation (Mazda) partnered with Ford Motor Company (Ford), helping Ford in small-car engineering and lean manufacturing in exchange for finance and marketing know-how; however, this alliance was terminated due to the global financial crisis in 2008. In 2015, Mazda entered into another long-term partnership to share technologies and cope with cost pressures—this time with Toyota Motor Corporation (Toyota). According to...Starting at €8.20
-
Catalys Pacific
Krieger, Joshua LevCase HBS-821035-EKnowledge and CommunicationIn 2019, BT Slingsby founds Catalys Pacific, the first biotech "venture creation" fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After examining hundreds of potential investment opportunities, his team must decide which deals to pursue first. How can Catalys Pacific establish a positive investment track record whi...Starting at €8.20
-
The "Wonder Drug" that Killed Babies
Krieger, Joshua Lev; Nicholas, Tom; Preble, MatthewCase HBS-818044-EEconomicsIn the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children may have been affected. Just a handful of these children were born in the U.S., where safety concerns were raised by Dr. Frances Oldham Kelsey, the medical officer handling the thali...Starting at €8.20